- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Taiwanese Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record
Results
6
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
6 companies
Sunmax Biotechnology
Market Cap: NT$21.5b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$395.00
7D
0.3%
1Y
43.1%
Handa Pharmaceuticals
Market Cap: NT$19.0b
A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.
6620
NT$120.00
7D
0%
1Y
106.9%
Ever Supreme Bio Technology
Market Cap: NT$14.5b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$165.50
7D
4.1%
1Y
4.9%
Savior Lifetec
Market Cap: NT$5.9b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$18.15
7D
0.6%
1Y
-9.9%
Maxigen Biotech
Market Cap: NT$3.6b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$44.45
7D
6.1%
1Y
6.1%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.5b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$76.50
7D
-2.0%
1Y
-20.4%